Archive · 24 Jul 2025
Infosys Reports Strong Quarter; Analysts Weigh in on Stock Performance
Infosys, a big technology company, did well in the last few months, making more money than expected.
They think they'll keep doing okay in the future, but aren't super optimistic.
Some experts think the company's a good deal and suggest buying, while others are more cautious, saying to wait and see.
The experts are keeping an eye on how much money companies are spending on technology, as the economy isn't fully stable.
Overall, Infosys seems to be doing alright, but there's still a bit of uncertainty about what will happen next.
Infosys reported strong June quarter results, exceeding expectations for revenue, profit growth, and deal wins.
The company raised the lower end of its FY26 guidance to 1-3%, but maintained a cautious outlook.
Analysts have a neutral to positive stance, citing inexpensive valuations after a 17% decline.
Management noted a continued 'wait-and-watch' approach among clients amid macroeconomic uncertainty.
Nuvama upgraded its target multiple and maintained a 'Buy' rating, while MOFSL maintained a 'Neutral' rating.
- Who
- Infosys, analysts from MOFSL and Nuvama.
- What
- Infosys reported strong financial results for the June quarter and raised its FY26 guidance.
- When
- The financial results were for the June quarter.
- Where
- Not explicitly mentioned in the article.
- Why
- The company's performance and future outlook are affected by macroeconomic conditions, client spending, and valuations.
Analyst Perspectives on Infosys Stock
Positive and Cautious
Investment Recommendation
Analyst Perspectives on Infosys Stock
MOFSL maintains a 'Neutral' rating, citing limited near-term catalysts despite promising work in Enterprise AI.
Positive and Cautious
Nuvama maintains a 'Buy' rating, expecting growth in the medium to long term as technology debt warrants increased spending.
- FY26 Guidance
- 1-3% (lower end raised)
- Analyst Ratings
- Neutral to Positive
- Valuations
- Inexpensive after a 17% decline
- MOFSL Rating
- Neutral
- Nuvama Rating
- Buy
- Nuvama Target Price
- Rs 1,850
- MOFSL Target Price
- Rs 1,750